Tag: Drug Development

Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19

Takeda Pharmaceutical Company Limited will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat ...

Gilead Sciences to Acquire Forty Seven for $4.9 Billion

Gilead Sciences, Inc. and Forty Seven, Inc. announced that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Forty Seven for $95.50 per share in cash. The tr...

Orphan drugs face uphill battle in 2020

As patients, clinicians and researchers prepare for Rare Disease Day on February 29 2020, GlobalData’s analysis shows the number of drugs awarded orphan drug designations (ODDs) by both the Food and D...

Biogen and Sangamo Announce Global Collaboration to Develop Gene Regulation Therapies

Biogen Inc. and Sangamo Therapeutics, Inc., a genomic medicine company, announced that they have executed a global licensing collaboration agreement to develop and commercialize ST-501 for tauopathies...

Russian Scientists Have Created a New Drug for Influenza

A group of researchers that included staff of TSU, the Institute for Problems of Chemical and Energetic Technologies of the Siberian Branch of the RAS (IPCET SB RAS, Biysk), and the Research Institute...

Novartis and DNDi Have Signed a Collaboration to Jointly Develop a New Oral Drug

Novartis and the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, have signed a collaboration and licence agreement to jointly develop ...

Janssen Strengthens Collaboration with BARDA in an Effort to Stem COVID-19 Outbreak

Johnson & Johnson announced that its Janssen Pharmaceutical Companies will expand its existing partnership with the Biomedical Advanced Research and Development Authority (BARDA), part of the Offi...

The Biopharmaceutical Industry is Currently Developing Nearly 600 Pediatric Medicines

America’s biopharmaceutical researchers are committed to studying, developing and testing medicines to meet the unique needs of pediatric patients. New treatment options for infants, children and adol...

The First Vaccine Against Coronavirus (COVID-19) could be Ready in 18 Months

The first samples of a vaccine against the novel coronavirus may be ready in 18 months, World Health Organization (WHO) Director General Tedros Adhanom Ghebreyesus said during a briefing in Geneva. "...

Russia has Developed a Prototype Drug for the Treatment of Chronic Depression

Russian molecular biologists and mathematicians have calculated a formula for a short protein molecule, capable of suppressing many forms of clinical depression without causing serious side effects, s...

Kleo Receives IND Authorization to Proceed from FDA for its Multiple Myeloma Therapeutic

Kleo Pharmaceuticals, Inc., an immuno-oncology company developing next-generation, fully synthetic bispecific compounds designed to emulate or enhance the activity of biologics, announced that it has ...

Russian Drug Triazavirin Being Tested in China as Treatment for New Coronavirus

Russia’s new antiviral drug Triazavirin is being tested in China as treatment for the novel coronavirus, Russian Deputy Health Minister Sergei Krayevoi said on February 4. "The Chinese have taken Tri...

BioMotiv and Bristol-Myers Squibb Announce the Launch of Anteros Pharmaceuticals

BioMotiv, a mission-driven drug development accelerator associated with The Harrington Project for discovery and development, that advances breakthrough discoveries from research institutions into the...

The Development and New Treatments Received the most Funding in the UK over the 14 Years

A report has revealed that in the UK in 2018, £4.8 million of funding was contributed to scientific development in support of research to improve human health. The researchers, from UK Research and...

President RF: Russia Has Many Qualified Epidemiologists Who are Developing Vaccines

Russian President Vladimir Putin hopes that the measures taken to combat the spread of a novel coronavirus will be effective, reminding that Russia has many qualified epidemiologists who developed a d...

Sistema and International Medical Cluster Foundation Launch Development of Biotech R&D Lab

Sistema PJSFC, a publicly traded diversified Russian holding company, and its portfolio company Sistema-Biotech announce signing an investment agreement with the International Medical Cluster Foundati...